AmerisourceBergen To Pay $260M After Mislabeling Drugs
A subsidiary of pharmaceutical giant AmerisourceBergen Corp. pled guilty Wednesday in a Brooklyn federal court to violating federal rules on the packaging and distribution of drugs and agreed to pay $260...To view the full article, register now.
Already a subscriber? Click here to view full article